Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Earnings
Pharma
WuXi Biologics stays the course with positive 2024 outlook
Amid a national-security-related reckoning in the U.S., Chinese contract manufacturer WuXi Biologics is accentuating the positive.
Fraiser Kansteiner
Mar 27, 2024 1:44pm
Novo, Novartis, Merck KGaA, Kyowa Kirin—Fierce Pharma Asia
Mar 22, 2024 8:45am
EuroAPI suspends 2024 guidance amid Italian production deficits
Mar 15, 2024 11:12am
Coherus lays off 30% of employees amid new 'sharpened focus'
Mar 13, 2024 6:10pm
Legend CEO offers preview of high-stakes FDA adcomm for Carvykti
Mar 11, 2024 1:29pm
Amid launch hurdles, Eisai updates Leqembi's sales forecast
Mar 7, 2024 11:29am